As part of the agreement, the companies will utilize GE’s global research center and its advanced work in clinical parameters and monitoring algorithms to drive innovation in the field of remote patient monitoring and diagnostics.
GE Healthcare will distribute and co-market Living Independently’s QuietCare products globally. It will also take a minority ownership stake in Living Independently.
Omar Ishrak, president and CEO of clinical systems business at GE Healthcare, said: “The technologies developed by Living Independently are ideally placed to help meet these challenges. They are also a great fit with our vision of helping people to live longer, healthier and higher quality lives.”